Come up with a name for your new list and we'll add to it:
SeptRx raised a round of funding on June 06, 2011. Investors include
Confluent Medical Technologies.
SeptRx is a cardiovascular medical device company that is developing a platform for the percutaneous transcatheter closure of a heart defect known as patent foramen ovale.…